Results There were 2041 HF admissions in 1612 patients with a median age of 67 years (mean 64 ± 14 years). Age >75 years was found in 24%, 49.6% were male patients, and 67% of these admissions had prior heart failure. Underlying diseases were hypertension [(HT) = 65%], coronary artery disease [(CAD) = 47%], dyslipidemia (50%), diabetes mellitus (47%), atrial fibrillation (24%) and chronic kidney disease (19%). Clinical features at presentation were dyspnea (97%), edema (60%), pulmonary rales (85%) and pulmonary congestion by chest X-ray (93%). Sixty-nine percent (69%) were in NYHA functional class IV and 44% had a left ventricular ejection fraction (LVEF) less than 40%. Common causes of heart failure were CAD (45%), valvular heart diseases (19%), cardiomyopathy (14%) and HT (12%). Precipitating causes of heart failure were heart disease itself 54% and 20% were related to inadequate diuretics and poor patient compliance with medications. Neurohormonal blockers (NHB) [angiotensin converting enzyme inhibitors (ACEI), angiotensinoge receptor blocker (ARB), aldosterone blocker (AA) and beta blockers (BB)], were given prior to hospitalization in comparison to at discharge in 26% vs. 35%, 12% vs. 12%, 13% vs. 17% and 26% vs. 24% respectively. In-hospital mortality rate was 5.5% and the median length of hospitalization was 7.5 days. Major causes of death were sepsis, worsening of heart failure, arrhythmic arrest and acute coronary syndrome. There was a higher mortality rate in those with poor LV systolic function compared to those with preserved LV systolic function (8.2% vs. 4.1%; p = .008). At discharge, 23% of the patients were asymptomatic while 69% had symptomatic improvement. Conclusion Thai ADHERE registry revealed that Thai patients hospitalized for heart failure are younger and sicker than European and American patients. There is a high prevalence of HF with preserved ejection fraction. CAD was the most common cause of HF while HT was the most common underlying disease. There was a 5.4% mortality rate, which was higher in those with poor LV systolic function. There was underutilization of NHB (ACEI, ARB, BB and AA). Keywords Thai ADHERE registry Heart failure Thai heart failure registry Neurohormonal blockers Introduction Heart failure is the one of the malignant cardiac syndromes which has a high morbidity and mortality rate all over the world. In Thailand, heart failure is one of the major cardiovascular health problems and economic burdens. In Europe, the prevalence of symptomatic heart failure (HF) is estimated to range from 0.4% to 2.0% [1] in the general population and the mean age of the HF population is 70 years [1,2] . In the US, data from Heart Disease and Stroke Statistics_2009 Update [3] indicate that: HF incidence approaches 10 per 1000 population after 65 years of age. Seventy-five percent of HF cases have antecedent hypertension follow closely by antecedent myocardial infarction. The range in incidence is 3.4–6.0 in whites and 8.1–9.1 in blacks per 1000 person-years. In 2005, 1 in 8 death certificates (292,214 deaths) in the United States mentioned heart failure. In Thailand there has been no epidemiologic HF data. This is the first epidemiologic study of heart failure in Thailand using the same protocol as the US ADHERE Registry [4,8] . The aim of this study is to assess the database of hospitalized patients with the diagnosis of heart failure (HF) or acute decompensated heart failure (ADHF) in Thailand in terms of patient characteristics, clinical presentations, and causes of heart failure, precipitating causes of heart failure, hospital course, management and hospital outcomes. This registry includes 18 participating cardiac centers (10 university hospitals, 3 government hospitals and five private hospitals). The Thai ADHERE investigators hope that this data will give information about heart failure management. The data should help us to improve our heart failure management, applying appropriate practice guidelines for HF and lowering the mortality and morbidity from HF in Thailand. Materials and methods Thai Acute Decompensate Heart Failure Registry or Thai ADHERE registry is a phase IV multi-center prospective observational and open-label registry study. Methods are the same as US ADHERE [4,8] . In brief, it enrolled consecutively hospitalized patients age more than 18 years with a post discharge diagnosis of HF in 18 cardiovascular centers from March 2006 to November 2007. Patients with cardiogenic shock, perioperative heart failure and the patients who present HF as a co-morbid condition but not a principal focus of diagnosis or treatment were excluded. Data were collected from each medical summary beginning with the point of initial care and/or emergency department and ending when the patient was discharged or transferred out of the hospital or in-hospital death. Heart failure (HF) or decompensated HF was determined clinically by the cardiologists. ADHF is clinically defined as new-onset HF with decompensation or chronic HF with decompensation. Entry was based upon the presence of ADHF and not tied to the use of any specific therapeutic agent or regimen. Each institution was instructed to identify and capture all consecutive eligible subjects. Data collection Data, captured via the case record form (CRF), include demographic characteristics, medical history, initial evaluation, clinical presentations, hospital course, medications given prior to admission and at discharge, procedures, disposition status, discharge instruction, causes and precipitating causes of heart failure and mortality. The data were collected via a web-based electronic data capture (EDC) system provided by Scios company. Participating centers entered data via customized electronic case report forms and all data were checked for validity. To preserve patient’s anonymity, there was no collection of unique patient identifying information. The Longitudinal Unique...